Case report identifies complex diagnostic challenges in McArdle disease mimics, implying the need for advanced testing methods.
McArdle disease is inherited in an autosomal recessive pattern, with classical disease manifesting with biallelic pathogenic variants in the PYGM (myophosphorylase) gene. Here, we present a case of a 77-year-old man with a paraspinal myopathy and head drop with cytochrome c oxidase (COX)-negative fibers who is a heterozygous carrier of a pathogenic c.148C>T (p.Arg50*) nonsense variant in PYGM as identified on a comprehensive glycogen storage disease gene panel through Mayo Clinic Laboratories. Two findings complicate a confident diagnosis of classical McArdle disease. They are explicitly addressed: a single (heterozygous) pathogenic allele for an autosomal recessive disorder, and COX-negative fibers in the absence of frank glycogen accumulation on periodic acid-Schiff staining. The case is presented as suggestive of an atypical metabolic-mitochondrial phenotype, and we discuss the diagnostic limitations of a blood-based targeted gene panel, as well as further testing, including muscle RNA sequencing and tissue-specific mitochondrial DNA analysis, that could resolve a potentially undetected second variant or a tissue-restricted mitochondrial etiology.
No takes yet. Share an insight, caveat, or question.
Blackbourn et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: